+987.9%
MRNA vs CRS
-3.8%
+991.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CRS | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -1.6% | +14.7% | +13.2% |
| 7D | +20.6% | +4.3% | +16.3% | +20.1% |
| 30D | +27.1% | -25.5% | +52.6% | +29.0% |
| 3M | +353.4% | -48.7% | +402.1% | +350.2% |
| 6M | +446.3% | -31.6% | +477.9% | +403.3% |
| YTD | +776.2% | -7.0% | +783.2% | +656.9% |
| 1Y | +987.9% | -4.5% | +992.4% | +825.7% |
| All | +987.9% | -3.8% | +991.7% | +825.7% |
Cumulative growth
Daily Returns
Daily percentage return beside CRS.
Daily Out/Under-Performance
Portfolio return minus CRS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CRS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CRS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling